Curcumin-based IKKβ inhibiting anticancer lead design using novel fragment-based group QSAR modelling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Curcumin-based IKKβ inhibiting anticancer lead design using novel fragment-based group QSAR modelling

Published:2014-10-10 Issue:5 Volume:24 Page:2022-2032
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Patel Kunal,Tyagi Chetna,Goyal Sukriti,Dhanjal Jaspreet Kaur,Bharadvaja Navneeta,Grover Abhinav

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/s00044-014-1274-8.pdf

Reference45 articles.

1. Afantitis A, Melagraki G, Sarimveis H, Igglessi-Markopoulou O, Kollias G (2009) A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas. Eur J Med Chem 44:877–884

2. Alexander G, Alexander T (2002) Beware of Q2! J Mol Gr Model 20:269–276

3. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB (2007) Bioavailability of curcumin: problems and promises. Mol Pharm 4:807–818

4. Baldwin AS (2001) Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. J Clin Invest 107:241–246

5. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dörken B (1997) Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin’s disease tumor cells. J Clin Invest 100:2961

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cheminformatics approaches to predict the bioactivity and to discover the pharmacophoric traits crucial to block NF-κB;Chemical Physics Impact;2024-12

2. In silico drug discovery of IKK-β inhibitors from 2-amino-3-cyano-4-alkyl-6-(2-hydroxyphenyl) pyridine derivatives based on QSAR, docking, molecular dynamics and drug-likeness evaluation studies;Journal of Biomolecular Structure and Dynamics;2020-09-18

3. Natural polyphenolic inhibitors against the antiapoptotic BCL-2;Journal of Receptors and Signal Transduction;2017-03-06

4. Molecular dynamics-based identification of novel natural mortalin–p53 abrogators as anticancer agents;Journal of Receptors and Signal Transduction;2016-07-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3